Fierce covers CLCC collaboration with Merck
Press releases
Calla Lily Clinical Care and Merck announce Strategic Collaboration to advance Intravaginal Drug Delivery Platform
London, UK – Calla Lily Clinical Care, a women’s health-focused medical technology company, and Merck, a leading science and technology company, have entered a strategic collaboration to support the continued development of Callavid®, a novel platform for intravaginal drug delivery. The collaboration represents the first industry partnership for the Callavid® technology. Callavid is a transformational leak-resistant …
Pioneering technology to address threatened miscarriage secures £1 million funding and moves towards clinical trials
London, UK – A team of scientists and biomedical engineers developing pioneering technology designed to treat threatened miscarriage has secured £1 million in Invention for Innovation (i4i) funding from the National Institute for Health and Care Research (NIHR) for its first clinical trial. The new technology is a novel device designed to improve the delivery …
